Central sensitization measures track with worse pain after peripheral procedures
A systematic review and meta-analysis in adults with chronic pain found a consistent pattern: higher scores on central sensitization-related measures, or psychophysical findings suggestive of nociceptive facilitation, tended to line up with less favorable outcomes after invasive peripheral procedures. The clearest signal involved post-intervention pain intensity, which rose in parallel with higher Central Sensitization Inventory scores and enhanced temporal summation across the studies that could be pooled.
The review brought together 24 studies and 3494 participants across chronic pain conditions that included low back pain, knee and hip osteoarthritis, endometriosis-related pain, shoulder pain, and abdominal nerve entrapment. Twelve of those studies fed into the quantitative synthesis. The pooled estimate for post-intervention pain intensity was substantial: Cohen’s d was 1.1074 with a 95% confidence interval from 0.7060 to 1.5089, and heterogeneity was high at I2 = 88.35%.
Why pain processing matters before a peripheral intervention
Persistent pain is not governed only by the tissue that is cut, injected, or ablated. In many patients, the central nervous system amplifies incoming sensory input, so a peripheral procedure may repair or address the local generator while the broader pain-processing system continues to magnify symptoms. Elevated CSI scores and enhanced temporal summation point toward that biology: a nervous system that has become easier to excite and slower to quiet.
In practical terms, this means a patient can have a technically successful intervention and still report a disappointing pain response. The review’s pattern fits that bedside reality. Measures reflecting nociceptive facilitation were repeatedly associated with greater residual pain after intervention, suggesting that central pain processing may shape how much benefit a peripheral approach can deliver.
The studies did not speak with one voice, however. Clinical conditions differed, interventions differed, and the tools used to characterize central sensitization-related phenomena were not uniform. Some studies relied on self-report, most commonly the CSI, while others used psychophysical testing. Those different approaches are related but not interchangeable, and the review treats them as evidence of central pain-processing features rather than proof of a single biologic state.
The pooled signal was strong, but the evidence base was uneven
A single sentence captures the tension in this literature: the association looked meaningful, yet the underlying evidence was fragile.
Under a conservative overall classification rule, 21 studies were rated at high risk of bias and three at moderate risk. That imbalance forces a cautious reading of the pooled effect. When most of the evidence comes from studies with important design limitations, the size of the observed association can be inflated, deflated, or made less precise by confounding, selection effects, or inconsistent measurement.
Substantial clinical and methodological heterogeneity ran through the dataset as well. Different pain syndromes, different procedures, different outcome definitions, and different ways of capturing central sensitization-related features all limit the ability to treat the pooled estimate as a universal predictor. A high CSI score in one population does not guarantee the same prognostic meaning in another, and temporal summation testing may carry different weight depending on the intervention being studied.
Even so, the direction of the relationship was not random. Higher central sensitization-related scores or psychophysical findings were generally associated with worse clinical outcomes, particularly greater pain intensity after the procedure. The consistency of that direction across a mixed chronic pain literature makes the signal clinically hard to ignore, even if the exact magnitude remains uncertain.
What clinicians can and cannot conclude from the data
The review supports a focused clinical inference: preprocedural assessment of pain processing may help identify patients less likely to achieve robust pain relief from invasive peripheral treatment alone. It does not support overclaiming. These findings should not be read as direct measurement of central sensitization itself, and they do not show that any one self-report scale or psychophysical test uniformly predicts outcomes across all chronic pain settings.
That distinction is especially important in chronic pain care, where a patient’s symptom burden often reflects both peripheral pathology and central amplification. A procedure aimed at the peripheral source may still be appropriate, but the expected ceiling of benefit may differ when pain processing is already sensitized. Multimodal care could be more realistic in such patients, combining peripheral intervention with strategies that address central pain modulation, though this review did not test treatment combinations.
One sentence bears repeating in clinical terms: the nervous system appears to matter after the needle, scalpel, or ablation has done its work.
Standardized testing remains the next step
The authors call for further prospective studies using standardized and multimodal assessments of central pain processing. That request follows directly from the limitations of the current evidence base. Future work needs clearer definitions, more consistent tools, and better alignment between baseline pain-processing measures and procedure-specific outcomes.
Prospective designs would also help separate prognostic signal from confounding. Patients with more severe pain, longer symptom duration, or higher psychological burden may score differently on central sensitization-related tools before treatment, and those same factors can influence post-procedure pain independently. Without tighter study design, it remains difficult to know how much of the observed association reflects central pain biology itself and how much reflects overlapping clinical complexity.
For now, the most defensible reading is narrow but important: higher CSI scores and psychophysical findings linked to nociceptive facilitation were associated with less favorable pain outcomes after invasive peripheral procedures in chronic pain populations. The association is substantial, the heterogeneity is high, and the risk of bias is widespread. Better prospective studies will have to determine which measures are useful at the bedside and which are too inconsistent to guide care reliably.